ANI Pharmaceuticals, Inc. (ANIP) NASDAQ

61.79

+3.0705(+5.23%)

Updated at June 02 03:24PM

Currency In USD

ANI Pharmaceuticals, Inc.

Address

210 Main Street West

Baudette, MN 56623

United States of America

Phone

218 634 3500

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

897

First IPO Date

May 05, 2000

Key Executives

NameTitlePayYear Born
Mr. Nikhil LalwaniPresident, Chief Executive Officer & Director2.44M1978
Ms. Meredith W. Cook J.D.Senior Vice President, General Counsel & Corporate Secretary845,5001974
Mr. Chad GassertSenior Vice President of Corporate Development & Strategy849,7111976
Mr. Christopher K. MutzSenior Vice President & Head of Rare Disease919,6631972
Mr. Ori GutwergSenior Vice President of Generics930,9621975
Mr. Stephen P. CareySenior Vice President of Finance & Chief Financial Officer1.14M1971
Ms. Elizabeth Powell J.D.Chief Compliance Officer & Head of Legal of Rare Disease0N/A
Ms. Krista L. DavisSenior Vice President & Chief Human Resources Officer01973
Dr. Mary Pao M.D., Ph.D.Chief Medical Officer0N/A
Mr. Muthusamy Shanmugam MS R.Ph.Head of R&D, Chief Operating Officer of New Jersey Operations & Director01968

Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.